Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for blood cancer patients in japan?

NCT ID NCT06035497

Ongoing Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Apr 29, 2026 · Last updated Jun 17, 2026 · Updated 10 times

Summary

This study is testing a new drug called Golcadomide (BMS-986369) in about 85 people in Japan whose T-cell lymphoma has come back or not responded to treatment. The goal is to check the drug's safety and how well it works against the cancer. Participants will receive the drug and be monitored for side effects and tumor response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTRANODAL NK/T-CELL LYMPHOMA, NASAL TYPE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Local Institution - 0001

    Sendai, Miyagi, 980-8574, Japan

  • Local Institution - 0002

    Kashiwa, Chiba, 277-8577, Japan

  • Local Institution - 0003

    Chuo-ku, Tokyo, 104-0045, Japan

  • Local Institution - 0004

    Isehara, Kanagawa, 259-1193, Japan

  • Local Institution - 0005

    Ōsaka-sayama, Osaka, 589-8511, Japan

  • Local Institution - 0006

    Kumamoto, 860-8556, Japan

  • Local Institution - 0007

    Okayama, 700-8558, Japan

  • Local Institution - 0008

    Kagoshima, 890-8520, Japan

  • Local Institution - 0009

    Hidaka, Saitama, 350-1298, Japan

  • Local Institution - 0010

    Osaka, 541-8567, Japan

  • Local Institution - 0011

    Nagoya, Aichi-ken, 467-8602, Japan

  • Local Institution - 0012

    Fukuoka, 812-8582, Japan

  • Local Institution - 0013

    Yokosuka, Kanagawa, 238-8558, Japan

  • Local Institution - 0015

    Kagoshima, 890-0064, Japan

  • Local Institution - 0016

    Iizuka, Fukuoka, 820-8505, Japan

  • Local Institution - 0017

    Kamogawa, Chiba, 296-0041, Japan

  • Local Institution - 0018

    Fukuoka, 810-8563, Japan

  • Local Institution - 0019

    Ōmura, Nagasaki, 8568562, Japan

  • Local Institution - 0020

    Ōita, 870-8511, Japan

  • Local Institution - 0022

    Mitaka, 181-8611, Japan

  • Local Institution - 0023

    Fukuoka, 814-0180, Japan

  • Local Institution - 0024

    Toyohashi, Aichi-ken, 441-8570, Japan

  • Local Institution - 0025

    Hiroshima, 7348551, Japan

  • Local Institution - 0026

    Minato-ku, Tokyo, 105-8471, Japan

  • Local Institution - 0027

    Kyoto, 602-8566, Japan

  • Local Institution - 0028

    Sasebo, Nagasaki, 857-8511, Japan

  • Local Institution - 0029

    Itabashiku, Tokyo, 173-8610, Japan

  • Local Institution - 0030

    Nagasaki, 852-8104, Japan

  • Local Institution - 0031

    Anjo-shi, Aichi-ken, 446-8602, Japan

  • Local Institution - 0032

    Amagasaki, Hyōgo, 660-8550, Japan

  • Local Institution - 0033

    Kobe, Hyōgo, 650-0047, Japan

  • Local Institution - 0034

    Osaka, 545-8586, Japan

  • Local Institution - 0035

    Kumamoto, 860-0008, Japan

  • Local Institution - 0036

    Sapporo, Hokkaido, 0608648, Japan

  • Local Institution - 0037

    Narita, Chiba, 286-8520, Japan

  • Local Institution - 0038

    Miyazaki, 889-1692, Japan

  • Local Institution - 0039

    Hiroshima, 730-0052, Japan

  • Local Institution - 0040

    Koto, Tokyo, 135-8550, Japan

  • Local Institution - 0041

    Kitakyushu-shi, Fukuoka, 806-8501, Japan

  • Local Institution - 0042

    Okinawa, 904-2142, Japan

Conditions

The condition(s) this trial relates to.

adult T-cell leukemia/lymphoma ALK-negative anaplastic large cell lymphoma ALK-positive anaplastic large cell lymphoma anaplastic large cell lymphoma angioimmunoblastic T-cell lymphoma breast implant-associated anaplastic large cell lymphoma extranodal nasal NK/T cell lymphoma Leukemia-Lymphoma, Adult T-Cell lymphoma Lymphoma, Extranodal NK-T-Cell mature T-cell and NK-cell non-Hodgkin lymphoma mycosis fungoides peripheral T-cell lymphoma, not otherwise specified Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Recurrence T-cell non-Hodgkin lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RELAPSED OR REFRACTORY T-CELL LYMPHOMAS